Circulatory microRNA-145 expression is increased in cerebral ischemia

C S Gan1, C W Wang, K S Tan

  • 1Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. mr.dennisgan@gmail.com

Insights

Circulating microRNA-145 levels are significantly elevated in patients with ischemic stroke compared to healthy individuals. This finding suggests microRNA-145 may serve as a novel biomarker for stroke diagnosis and understanding hemostatic alterations.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Cerebral ischemia, or ischemic stroke, primarily stems from vascular and circulation issues.
  • While protein biomarkers are known, RNA profiles, including microRNAs, are emerging as potential stroke markers.
  • MicroRNA-145 (miR-145) is recognized for its role in vascular smooth muscle cell phenotype, but its expression in ischemic stroke was unexamined.

Purpose of the Study:

  • To investigate the expression levels of circulatory microRNA-145 in patients with ischemic stroke.
  • To determine if microRNA-145 can serve as a biomarker for ischemic stroke.

Main Methods:

  • Real-time quantitative PCR was used to analyze circulatory microRNA-145 expression.
  • The study included 32 ischemic stroke patients and 14 healthy control subjects.

Main Results:

  • Circulatory microRNA-145 expression was significantly higher in ischemic stroke patients compared to healthy controls.
  • The elevated levels indicate that hemostatic mechanisms are impacted by ischemic stroke.

Conclusions:

  • Circulating microRNA-145 shows potential as a diagnostic biomarker for ischemic stroke.
  • Further research is warranted to explore the role of miR-145 in stroke pathophysiology and hemostasis.